Therapy Areas: Oncology
24 August 2026 - Biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) announced on Monday that the European Commission has approved Trodelvy (sacituzumab govitecan-hziy) with Keytruda (pembroli...
24 August 2026 - Biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) announced on Monday that the US Food and Drug Administration (FDA) has accepted for priority review its supplemental Biologics L...
24 August 2026 - Anbogen Therapeutics Inc (TPEx:7784), a Taiwan-based, clinical-stage precision oncology company, announced on Sunday that it has entered into a Collaborative Research Agreement (CRA) ...
21 August 2026 - China-based biotechnology company Nanjing Leads Biolabs Co., Ltd. (HKG: 9887) said on Friday that the Centre for Drug Evaluation of the National Medical Products Administration has ac...
21 August 2026 - French biopharmaceutical company Ipsen (Euronext Paris:IPN) (ADR:IPSEY) announced on Friday that it has completed the acquisition of Kartos Therapeutics, adding the clinical-stage bio...
21 August 2026 - Global oncology company Nuvation Bio Inc (NYSE:NUVB) announced on Thursday that the US Food and Drug Administration (FDA) has granted Fast Track Designation for safusidenib, the compa...